(Q50919806)

25 March 2018

title

Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China. (English)

1 reference

25 March 2018

amyotrophic lateral sclerosis

main subject

0 references

author name string

Chengyu Li

1

1 reference

25 March 2018

Ying Ji

2

1 reference

25 March 2018

Lu Tang

3

1 reference

25 March 2018

Nan Zhang

4

1 reference

25 March 2018

Ji He

5

1 reference

25 March 2018

Shan Ye

6

1 reference

25 March 2018

Xiaolu Liu

7

1 reference

25 March 2018

Dongsheng Fan

8

1 reference

25 March 2018

publication date

26 October 2015

1 reference

25 March 2018

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

published in

1 reference

25 March 2018

volume

16

1 reference

25 March 2018

issue

7-8

1 reference

25 March 2018

page(s)

485-489

1 reference

25 March 2018

Mutations of optineurin in amyotrophic lateral sclerosis

cites work

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

The distinct genetic pattern of ALS in Turkey and novel mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Toward an integrative view of Optineurin functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Adult-onset primary open-angle glaucoma caused by mutations in optineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2015.1089909

10.3109/21678421.2015.1089909

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

26503823

1 reference

25 March 2018